Intuitive Surgical Inc. (NASDAQ:ISRG) Director Lonnie M. Smith sold 275 shares of the company’s stock in a transaction dated Thursday, November 17th. The shares were sold at an average price of $646.50, for a total value of $177,787.50. Following the sale, the director now owns 235,890 shares in the company, valued at $152,502,885. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

Shares of Intuitive Surgical Inc. (NASDAQ:ISRG) opened at 662.09 on Tuesday. Intuitive Surgical Inc. has a 52 week low of $502.01 and a 52 week high of $727.25. The company has a 50-day moving average price of $680.52 and a 200-day moving average price of $672.62. The stock has a market cap of $25.65 billion, a price-to-earnings ratio of 35.71 and a beta of 0.55.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings data on Tuesday, October 18th. The company reported $6.19 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $5.13 by $1.06. Intuitive Surgical had a return on equity of 15.02% and a net margin of 27.51%. The business had revenue of $682.90 million for the quarter, compared to the consensus estimate of $650.49 million. During the same quarter in the previous year, the company posted $5.24 EPS. The company’s revenue was up 15.8% compared to the same quarter last year. Equities analysts anticipate that Intuitive Surgical Inc. will post $22.19 EPS for the current year.

Insider Buying and Selling by Quarter for Intuitive Surgical (NASDAQ:ISRG)

Hedge funds have recently added to or reduced their stakes in the company. FMR LLC increased its stake in Intuitive Surgical by 15.5% in the second quarter. FMR LLC now owns 2,190,718 shares of the company’s stock worth $1,448,962,000 after buying an additional 294,511 shares during the last quarter. JPMorgan Chase & Co. increased its stake in Intuitive Surgical by 87.7% in the second quarter. JPMorgan Chase & Co. now owns 619,160 shares of the company’s stock worth $409,519,000 after buying an additional 289,330 shares during the last quarter. BlackRock Fund Advisors increased its stake in Intuitive Surgical by 24.3% in the second quarter. BlackRock Fund Advisors now owns 831,970 shares of the company’s stock worth $550,273,000 after buying an additional 162,789 shares during the last quarter. Eaton Vance Management increased its stake in Intuitive Surgical by 299.4% in the second quarter. Eaton Vance Management now owns 146,206 shares of the company’s stock worth $96,702,000 after buying an additional 109,600 shares during the last quarter. Finally, Vanguard Group Inc. increased its stake in Intuitive Surgical by 3.4% in the second quarter. Vanguard Group Inc. now owns 2,326,605 shares of the company’s stock worth $1,538,841,000 after buying an additional 77,521 shares during the last quarter. 90.97% of the stock is currently owned by institutional investors and hedge funds.

Several equities research analysts have recently weighed in on ISRG shares. Barclays PLC reiterated an “overweight” rating and set a $760.00 price target (up from $750.00) on shares of Intuitive Surgical in a research report on Friday, October 21st. Royal Bank Of Canada upped their price target on Intuitive Surgical from $750.00 to $760.00 and gave the company a “sector perform” rating in a research report on Wednesday, October 19th. Zacks Investment Research cut shares of Intuitive Surgical from a “buy” rating to a “hold” rating in a research report on Tuesday, September 20th. Wedbush restated an “outperform” rating and issued a $755.00 price objective (down from $785.00) on shares of Intuitive Surgical in a research report on Wednesday, October 19th. Finally, Wells Fargo & Co. initiated coverage on shares of Intuitive Surgical in a research report on Thursday, October 13th. They issued an “outperform” rating on the stock. One equities research analyst has rated the stock with a sell rating, six have assigned a hold rating, fourteen have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. The stock presently has an average rating of “Buy” and a consensus price target of $729.50.

About Intuitive Surgical

Intuitive Surgical, Inc (Intuitive) designs, manufactures and markets da Vinci Surgical Systems, and related instruments and accessories. The Company’s da Vinci Surgical System consists of a surgeon’s console, a patient-side cart and a vision system. The da Vinci Surgical System translates a surgeon’s hand movements, which are performed on instrument controls at a console, into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports.

5 Day Chart for NASDAQ:ISRG

Receive News & Stock Ratings for Intuitive Surgical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical Inc. and related stocks with our FREE daily email newsletter.